Brooktree Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,210
Closed -$441K 35
2022
Q1
$441K Sell
8,210
-9,950
-55% -$579K 0.29% 36
2021
Q4
$1.31M Sell
18,160
-1,740
-9% -$109K 0.8% 29
2021
Q3
$1.13M Sell
19,900
-2,620
-12% -$159K 0.72% 29
2021
Q2
$1.47M Hold
22,520
0.94% 29
2021
Q1
$1.34M Sell
22,520
-400
-2% -$21.8K 0.9% 31
2020
Q4
$1.08M Sell
22,920
-1,270
-5% -$53.4K 0.8% 30
2020
Q3
$802K Hold
24,190
0.68% 31
2020
Q2
$782K Hold
24,190
0.74% 30
2020
Q1
$581K Hold
24,190
0.67% 32
2019
Q4
$707K Buy
+24,190
New +$642K 0.65% 36

Other funds holding LRCX

Brooktree Capital Management's LRCX Position: Q2 2022 in Review

Brooktree Capital Management sold out of Lam Research (LRCX) in Q2 2022, closing a stake of 8,210 shares — an estimated $441K sold.

Brooktree Capital Management first reported a position in LRCX in Q4 2019 and held it in 10 quarters. The position peaked at $1.47M in Q2 2021. 1,307 funds tracked by Wall St. Rank hold LRCX as of Q2 2022.

  • Brooktree Capital Management reported no remaining Lam Research position as of Q2 2022 after selling out during the quarter.
  • Brooktree Capital Management sold 8,210 Lam Research shares in Q2 2022, an estimated $441K.
  • Brooktree Capital Management first reported a position in Lam Research in Q4 2019 and held it in 10 quarters.
  • Brooktree Capital Management's Lam Research position peaked at $1.47M in Q2 2021.
  • 1,307 funds tracked by Wall St. Rank held Lam Research as of Q2 2022.

Based on Brooktree Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.